Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage

Background: Anticancer action of sodium dichloroacetate (DCA) could be related to its ability to activate oxidative phosphorylation leading to enhanced generation of reactive oxygen species and induction of apoptosis. On the other hand, activation of oxidative phosphorylation could promote tumor cel...

Full description

Saved in:
Bibliographic Details
Published in:Experimental Oncology
Date:2016
Main Authors: Fedorchuk, A.G., Pyaskovskaya, O.N., Gorbik, G.V., Prokhorova, I.V., Kolesnik, D.L., Solyanik, G.I.
Format: Article
Language:English
Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2016
Subjects:
Online Access:https://nasplib.isofts.kiev.ua/handle/123456789/137992
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Cite this:Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage / A.G. Fedorchuk, O.N. Pyaskovskaya, G.V. Gorbik, I.V. Prokhorova, D.L. Kolesnik, G.I. Solyanik // Experimental Oncology. — 2016 — Т. 38, № 2. — С. 80–83. — Бібліогр.: 23 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-137992
record_format dspace
spelling Fedorchuk, A.G.
Pyaskovskaya, O.N.
Gorbik, G.V.
Prokhorova, I.V.
Kolesnik, D.L.
Solyanik, G.I.
2018-06-17T20:29:49Z
2018-06-17T20:29:49Z
2016
Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage / A.G. Fedorchuk, O.N. Pyaskovskaya, G.V. Gorbik, I.V. Prokhorova, D.L. Kolesnik, G.I. Solyanik // Experimental Oncology. — 2016 — Т. 38, № 2. — С. 80–83. — Бібліогр.: 23 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/137992
Background: Anticancer action of sodium dichloroacetate (DCA) could be related to its ability to activate oxidative phosphorylation leading to enhanced generation of reactive oxygen species and induction of apoptosis. On the other hand, activation of oxidative phosphorylation could promote tumor cell survival, in particular, via increased ATP synthesis. Such ambiguous effects of DCA could influence its anticancer effectiveness, depending on biological properties of a tumor, schedule of DCA administration and its dosage. The aim of the study was to analyze anticancer effect of DCA against glioma С6 in rats under conditions of different schedules of its administration and various dosages. Materials and Methods: The study was carried out in Wistar rats with intracerebrally transplanted glioma С6 cells. Therapy with DCA was performed as follows: daily for 6 days starting from the second day after tumor cell transplantation (schedule І) or 7th day (schedule ІІ) at a dose of 1.0 g/kg, or daily for 13 days starting from the second day at doses of 1.0; 1.5 or 4.5 g/kg (schedule ІІІ). An influence of hypoxia on anticancer effect of DCA was studied using hypoxic chambers where oxygen content was maintained at a level of 12.5–13% for 3 h after DCA administration to glioma С6 bearing rats. The state of mitochondrial electron transport chain components in tumor cells was studied using electron paramagnetic resonance. Results: It has been shown that therapy with DCA using schedule I resulted in 15% decrease of animals life span (LS; р < 0.05), while the use of schedule II had no effect on this index. Prolonged administration of DCA (schedule ІІІ) resulted in significant antitumor effect and increased LS of rats by 25.5% (p < 0.05). Under hypoxic conditions, treatment with DCA resulted in a significant increase of animal LS by 15–22%. Dosage of DCA had a moderate effect of its anticancer action. Maximal effect, an increase of LS by 34.5% (p < 0.05) was detected at a dose of 1.5 g/kg. It has been shown that anticancer activity of DCA under all studied conditions is not related to its influence on a functional state of tumor cell mitochondria. Conclusion: Anticancer effect of DCA significantly depends on a schedule of its administration; being administered at equal total dose, but dependent on the schedule DCA could cause ambiguous effects varying from tumor growth stimulation to significant anticancer activity. Under hypoxic conditions, anticancer efficacy of DCA against glioma С6 is significantly enhanced.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
spellingShingle Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
Fedorchuk, A.G.
Pyaskovskaya, O.N.
Gorbik, G.V.
Prokhorova, I.V.
Kolesnik, D.L.
Solyanik, G.I.
Original contributions
title_short Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
title_full Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
title_fullStr Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
title_full_unstemmed Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
title_sort effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage
author Fedorchuk, A.G.
Pyaskovskaya, O.N.
Gorbik, G.V.
Prokhorova, I.V.
Kolesnik, D.L.
Solyanik, G.I.
author_facet Fedorchuk, A.G.
Pyaskovskaya, O.N.
Gorbik, G.V.
Prokhorova, I.V.
Kolesnik, D.L.
Solyanik, G.I.
topic Original contributions
topic_facet Original contributions
publishDate 2016
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description Background: Anticancer action of sodium dichloroacetate (DCA) could be related to its ability to activate oxidative phosphorylation leading to enhanced generation of reactive oxygen species and induction of apoptosis. On the other hand, activation of oxidative phosphorylation could promote tumor cell survival, in particular, via increased ATP synthesis. Such ambiguous effects of DCA could influence its anticancer effectiveness, depending on biological properties of a tumor, schedule of DCA administration and its dosage. The aim of the study was to analyze anticancer effect of DCA against glioma С6 in rats under conditions of different schedules of its administration and various dosages. Materials and Methods: The study was carried out in Wistar rats with intracerebrally transplanted glioma С6 cells. Therapy with DCA was performed as follows: daily for 6 days starting from the second day after tumor cell transplantation (schedule І) or 7th day (schedule ІІ) at a dose of 1.0 g/kg, or daily for 13 days starting from the second day at doses of 1.0; 1.5 or 4.5 g/kg (schedule ІІІ). An influence of hypoxia on anticancer effect of DCA was studied using hypoxic chambers where oxygen content was maintained at a level of 12.5–13% for 3 h after DCA administration to glioma С6 bearing rats. The state of mitochondrial electron transport chain components in tumor cells was studied using electron paramagnetic resonance. Results: It has been shown that therapy with DCA using schedule I resulted in 15% decrease of animals life span (LS; р < 0.05), while the use of schedule II had no effect on this index. Prolonged administration of DCA (schedule ІІІ) resulted in significant antitumor effect and increased LS of rats by 25.5% (p < 0.05). Under hypoxic conditions, treatment with DCA resulted in a significant increase of animal LS by 15–22%. Dosage of DCA had a moderate effect of its anticancer action. Maximal effect, an increase of LS by 34.5% (p < 0.05) was detected at a dose of 1.5 g/kg. It has been shown that anticancer activity of DCA under all studied conditions is not related to its influence on a functional state of tumor cell mitochondria. Conclusion: Anticancer effect of DCA significantly depends on a schedule of its administration; being administered at equal total dose, but dependent on the schedule DCA could cause ambiguous effects varying from tumor growth stimulation to significant anticancer activity. Under hypoxic conditions, anticancer efficacy of DCA against glioma С6 is significantly enhanced.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/137992
citation_txt Effectiveness of sodium dichloroacetate against glioma с6 depends on administration schedule and dosage / A.G. Fedorchuk, O.N. Pyaskovskaya, G.V. Gorbik, I.V. Prokhorova, D.L. Kolesnik, G.I. Solyanik // Experimental Oncology. — 2016 — Т. 38, № 2. — С. 80–83. — Бібліогр.: 23 назв. — англ.
work_keys_str_mv AT fedorchukag effectivenessofsodiumdichloroacetateagainstgliomas6dependsonadministrationscheduleanddosage
AT pyaskovskayaon effectivenessofsodiumdichloroacetateagainstgliomas6dependsonadministrationscheduleanddosage
AT gorbikgv effectivenessofsodiumdichloroacetateagainstgliomas6dependsonadministrationscheduleanddosage
AT prokhorovaiv effectivenessofsodiumdichloroacetateagainstgliomas6dependsonadministrationscheduleanddosage
AT kolesnikdl effectivenessofsodiumdichloroacetateagainstgliomas6dependsonadministrationscheduleanddosage
AT solyanikgi effectivenessofsodiumdichloroacetateagainstgliomas6dependsonadministrationscheduleanddosage
first_indexed 2025-12-07T18:19:08Z
last_indexed 2025-12-07T18:19:08Z
_version_ 1850874578355617792